UA93032C2 - Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors - Google Patents
Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitorsInfo
- Publication number
- UA93032C2 UA93032C2 UAA200701488A UAA200701488A UA93032C2 UA 93032 C2 UA93032 C2 UA 93032C2 UA A200701488 A UAA200701488 A UA A200701488A UA A200701488 A UAA200701488 A UA A200701488A UA 93032 C2 UA93032 C2 UA 93032C2
- Authority
- UA
- Ukraine
- Prior art keywords
- kinase inhibitors
- map kinase
- formula
- disorder
- triazolopyridinylsulfanyl
- Prior art date
Links
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title abstract 2
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title abstract 2
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 6
- 201000010099 disease Diseases 0.000 abstract 4
- 230000000172 allergic effect Effects 0.000 abstract 2
- 208000010668 atopic eczema Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; Formula (I) and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease. EMBED ISISServer , (I)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0418015A GB0418015D0 (en) | 2004-08-12 | 2004-08-12 | New compounds |
| US69155905P | 2005-06-17 | 2005-06-17 | |
| PCT/IB2005/002574 WO2006018718A2 (en) | 2004-08-12 | 2005-08-09 | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93032C2 true UA93032C2 (en) | 2011-01-10 |
Family
ID=33017410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200701488A UA93032C2 (en) | 2004-08-12 | 2005-08-09 | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN101006087B (en) |
| GB (1) | GB0418015D0 (en) |
| ME (1) | ME01360B (en) |
| NI (1) | NI200700039A (en) |
| PE (1) | PE20060618A1 (en) |
| RS (1) | RS50642B (en) |
| TW (1) | TWI295926B (en) |
| UA (1) | UA93032C2 (en) |
| ZA (1) | ZA200700923B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2303267T3 (en) * | 2008-02-04 | 2013-11-29 | Pfizer Ltd | Polymorphic form of a [1, 2, 4] triazolo [4, 3-a]pyridine derivative for treating inflammatory diseases |
| AU2010215261A1 (en) * | 2009-02-17 | 2011-09-08 | Chiesi Farmaceutici S.P.A. | Triazolopyridine derivatives as p38 MAP kinase inhibitors |
| GB201009731D0 (en) * | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
| PE20141370A1 (en) * | 2011-12-09 | 2014-10-17 | Chiesi Farma Spa | KINASE INHIBITORS |
| CN105693716A (en) * | 2016-03-01 | 2016-06-22 | 孙霖 | Crystal form A and preparing method |
| CN105646484A (en) * | 2016-03-01 | 2016-06-08 | 孙霖 | Crystal form B and preparation method |
-
2004
- 2004-08-12 GB GB0418015A patent/GB0418015D0/en not_active Ceased
-
2005
- 2005-08-09 TW TW94126968A patent/TWI295926B/en not_active IP Right Cessation
- 2005-08-09 PE PE2005000916A patent/PE20060618A1/en not_active Application Discontinuation
- 2005-08-09 CN CN2005800274566A patent/CN101006087B/en not_active Expired - Fee Related
- 2005-08-09 UA UAA200701488A patent/UA93032C2/en unknown
- 2005-08-09 RS RSP-2008/0599A patent/RS50642B/en unknown
- 2005-08-09 ME MEP-2008-934A patent/ME01360B/en unknown
-
2007
- 2007-01-31 ZA ZA200700923A patent/ZA200700923B/en unknown
- 2007-02-09 NI NI200700039A patent/NI200700039A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200700923B (en) | 2008-09-25 |
| TWI295926B (en) | 2008-04-21 |
| CN101006087A (en) | 2007-07-25 |
| GB0418015D0 (en) | 2004-09-15 |
| ME01360B (en) | 2010-06-30 |
| PE20060618A1 (en) | 2006-07-14 |
| TW200610529A (en) | 2006-04-01 |
| CN101006087B (en) | 2010-09-29 |
| RS50642B (en) | 2010-06-30 |
| NI200700039A (en) | 2008-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY140021A (en) | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors | |
| UA105014C2 (en) | P38 map kinase inhibitors | |
| CY2021019I1 (en) | N4-PHENYL-QUINAZOLINO-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPLOVARATIVE DISEASES | |
| PL1689391T3 (en) | 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases | |
| TNSN08478A1 (en) | Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders | |
| MX2007014619A (en) | Pyrrolopyridines useful as inhibitors of protein kinase. | |
| UA115228C2 (en) | Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon | |
| UA92490C2 (en) | Imidazoquinolines as lipid kinase inhibitors | |
| NO20070453L (en) | Condensed heterocyclic kinase inhibitors | |
| SG179437A1 (en) | Pyrimidine hydrazide compounds as pgds inhibitors | |
| WO2007126964A3 (en) | Kinase inhibitors | |
| IL190411A (en) | Pyrimidine amide compounds as pgds inhibitors | |
| TW200738729A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
| ATE542800T1 (en) | KINASE INHIBITORS AND THEIR METHODS OF APPLICATION | |
| MX2010004967A (en) | Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer. | |
| TW200616967A (en) | Novel indazole carboxamides and their use | |
| WO2007124369A3 (en) | Method of inhibiting c kit kinase | |
| UA93032C2 (en) | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors | |
| WO2006128674A3 (en) | Combinations of indacaterol derivatives and other agents for the treatment of airway diseases | |
| DE60203106D1 (en) | AZOLYLCARBYNOL DERIVATIVES OF ARYL (OR HETEROARYL) FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| UY29057A1 (en) | DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS | |
| DOP2005000152A (en) | DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS |